Wang, M., Cohen, J., Shah, N., Jurczak, W., Zinzani, P. L., Cheah, C., Ujjani, C., Koh, Y., Kim, W. S., Nasta, S. D., Flinn, I., Tessoulin, B., Ma, S., Alencar, A., Lewis, D., Woyach, J., Maddocks, K., Patel, K., Wang, Y., Rhodes, J., Tam, C., Seymour, J., Nagai, H., Vose, J., Fakhri, B., Hoffmann, M., Hernandez-Ilizaliturri, F., Zelenetz, A., Kumar, A., Munir, T., Tsai, D., Abada, P., Balbas, M., Li, J., Wang, Y. (., Roeker, L., Eyre, T. (2025). Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Final update from the Phase 1/2 BRUIN study. Blood. https://doi.org/10.1182/blood-2025-665